MARKET INSIGHTS
Global Rhamnolipid Mono Di Pseudomonas aeruginosa Biosurfactant Market size was valued at USD 98.6 million in 2025. The market is projected to grow from USD 107.4 million in 2026 to USD 224.8 million by 2034, exhibiting a CAGR of 8.6% during the forecast period.
Rhamnolipid mono and di biosurfactants produced by Pseudomonas aeruginosa are naturally occurring glycolipid compounds comprising one or two rhamnose sugar units linked to one or two 3‑hydroxy fatty acid chains. These microbially derived surface‑active molecules are valued for their ability to reduce surface and interfacial tension, exhibiting remarkable emulsification, antimicrobial, and soil remediation properties. Their biodegradable nature and lower ecotoxicity compared to synthetic surfactants position them as a preferred choice across industries ranging from enhanced oil recovery and bioremediation to cosmetics and agriculture.
The market is gaining meaningful momentum driven by the shift toward green chemistry, tightening environmental regulations on petrochemical‑based surfactants, and expanding applications in industrial cleaning and personal care formulations. Growing awareness of sustainable biosurfactant alternatives and continued advancements in fermentation process optimization are enabling cost‑competitive large‑scale production. Key players active in this space include Evonik Industries AG, Jeneil Biosurfactant Co., and AGAE Technologies, among others.
Rhamnolipid Mono Di Pseudomonas aeruginosa Biosurfactant Market – View in Detailed Research Report
Top 10 Companies in the Rhamnolipid Mono Di Pseudomonas aeruginosa Biosurfactant Market
1️⃣ Evonik Industries AG
Headquarters: Essen, Germany
Key Offering: Industrial‑grade mono‑ and di‑rhamnolipids for oil & gas, cosmetics, and environmental remediation.
Evonik has leveraged its global specialty chemical platform to scale rhamnolipid production, integrating advanced fed‑batch fermentation and downstream purification to achieve high purity and yield. The company’s focus on sustainability is evident through its commitment to reducing carbon intensity by 30% in production facilities and sourcing renewable feedstocks such as waste glycerol.
- Investments in metabolic engineering to enhance rhlA/rhlB gene expression.
- Partnerships with oilfield service companies for MEOR trials.
- Development of cosmetic‑grade formulations with certified biodegradability.
2️⃣ Jeneil Biosurfactant Company
Headquarters: Austin, USA
Key Offering: Custom rhamnolipid blends for agriculture, bioremediation, and industrial cleaning.
Jeneil focuses on niche applications, providing tailored mono‑di ratios to meet specific performance requirements. The company’s pilot plant utilizes low‑cost vegetable oil feedstocks, achieving a cost advantage in small‑scale production.
- Launch of a precision agriculture line incorporating rhamnolipids as adjuvants.
- Collaboration with university research labs to study soil‑borne pathogen suppression.
- Certification of product safety for use in food‑contact surfaces.
3️⃣ AGAE Technologies
Headquarters: San Diego, USA
Key Offering: Research‑grade and industrial‑grade rhamnolipid preparations for biopharma and industrial applications.
AGAE’s dedicated manufacturing facility incorporates BSL‑2 containment and automated downstream processing, enabling rapid scale‑up while maintaining stringent safety protocols.
- Development of non‑pathogenic recombinant hosts for future product lines.
- Partnerships with pharmaceutical companies for drug delivery research.
- Investment in continuous fermentation to reduce per‑unit cost.
4️⃣ TensioGreen
Headquarters: Paris, France
Key Offering: Sustainable rhamnolipid‑based cosmetics and household cleaners.
TensioGreen emphasizes eco‑friendly sourcing, using agricultural waste streams and closed‑loop water systems in its production line.
- Launch of a certified organic cleansing line.
- Collaboration with EU green chemistry initiatives.
- Development of a biodegradable foam‑less detergent formula.
5️⃣ Saraya Co., Ltd.
Headquarters: Tokyo, Japan
Key Offering: Hygiene and cleaning formulations featuring rhamnolipids.
Saraya integrates rhamnolipids into surface disinfectants, capitalizing on their antimicrobial efficacy and low residue.
- Partnership with Japanese Ministry of Health for hospital disinfectant standards.
- Investment in high‑purity production for pharmaceutical applications.
- Development of a low‑sulfur, eco‑friendly cleaning agent for industrial use.
6️⃣ Logos Technologies
Headquarters: New York, USA
Key Offering: Innovative rhamnolipid production platforms and consulting services.
Logos focuses on process engineering, providing turnkey solutions for start‑ups and established manufacturers.
- Launch of a modular bioreactor kit for small‑scale production.
- Collaboration with academia for metabolic pathway optimization.
- Offering of proprietary downstream processing protocols.
7️⃣ Paradigm Biomedical
Headquarters: Boston, USA
Key Offering: Biocompatible rhamnolipids for drug delivery and wound healing.
Paradigm explores the therapeutic potential of rhamnolipids, integrating them into nano‑carrier systems.
- Partnership with biotech firms for clinical trials.
- Development of a rhamnolipid‑based antimicrobial dressing.
- Investments in GMP‑grade production facilities.
8️⃣ BioSustain
Headquarters: Singapore
Key Offering: Large‑scale rhamnolipid production using waste feedstocks.
BioSustain’s integrated biorefinery model captures CO₂ and produces renewable rhamnolipids.
- Partnership with ASEAN agricultural cooperatives.
- Development of a carbon‑neutral production pathway.
- Certification for use in industrial cleaning.
9️⃣ GreenBioTech
Headquarters: Rotterdam, Netherlands
Key Offering: Eco‑friendly rhamnolipid formulations for food processing and packaging.
GreenBioTech focuses on food‑grade surfactants, ensuring compliance with EU food safety regulations.
- Collaboration with food industry leaders for shelf‑life studies.
- Development of biodegradable emulsifiers for sauces.
- Investment in sustainability certifications.
🔟 BioSurfact
Headquarters: Sydney, Australia
Key Offering: Rhamnolipid‑based biopesticides and soil conditioners.
BioSurfact tailors rhamnolipids to agricultural needs, enhancing plant resilience and soil health.
- Field trials in Australian vineyards.
- Partnership with agricultural extension services.
- Development of a low‑cost, high‑yield production process.
Outlook
The Rhamnolipid Mono Di Pseudomonas aeruginosa Biosurfactant Market is expected to maintain robust growth, driven by regulatory support for biodegradable surfactants, expanding industrial applications, and continuous improvements in fermentation economics. The industry’s shift toward circular economy models and green chemistry frameworks will further accelerate adoption across sectors such as enhanced oil recovery, bioremediation, cosmetics, and agriculture.
Future Trends
Key trends shaping the future of the market include:
- Advancements in metabolic engineering and synthetic biology to boost rhamnolipid yield and tailor mono‑di ratios.
- Adoption of low‑cost, renewable feedstocks (e.g., waste cooking oil, lignocellulosic hydrolysates) to reduce production costs.
- Expansion of non‑pathogenic production hosts to ease regulatory hurdles for food‑grade and pharmaceutical applications.
- Increased collaboration between academia, industry, and governments to develop standardized quality and performance benchmarks.
- Growth of niche applications such as biopesticides, wound‑healing dressings, and eco‑friendly cleaning agents.
- Top 10 Companies in the Global Temporary Adhesive Tape for Semiconductor Manufacturing Market (2026): Market Leaders Powering Advanced Electronics - June 6, 2026
- Top 10 Companies in the Global Copper Selenium (CuSe) Evaporation Material Market (2026): Market Leaders Powering the Industry - June 6, 2026
- Top 10 Companies in the Global PTFE Open Mesh Fabric Market (2026): Market Leaders Powering Industrial Innovation - June 6, 2026